Summary
Anaerobic antibiotic susceptibility testing with standardized methods enabled the authors to speculate on the evolution of antibiotic resistance within theBacteroides fragilis group strains. Cefoxitin resistance was stable (0–5%) until 1985 and gradually increased later. Clindamycin resistance emerged in 1980 with a stable 10% resistance rate until 1986. An increase in clindamycin resistance developed in three institutions in 1987 [14]. No change was detected for imipenem and metronidazole, while piperacillin resistance increased since 1986. A comparison of antibiotic resistance rates is discussed for anaerobes in different countries.
Zusammenfassung
Standardisierte Methoden für die anaerobe Empfindlichkeitsprüfung ermöglichen es den Autoren, Vermutungen über die Entwicklung der Antibiotika-Resistenz innerhalb derBacteroides fragilis-Gruppe anzustellen. Die Cefoxitin-Resistenz war bis 1985 stabil (0–5%) und stieg danach langsam an. Die Clindamycin-Resistenz trat erst 1980 auf mit einer stabilen Resistenzrate von 10% bis 1986. Eine Steigerung der Resistenzraten von Clindamycin trat 1987 bei drei Instituten auf [14]. Keine Änderungen konnten für Imipenem und Metronidazol entdeckt werden, während die Piperacillin-Resistenz seit 1986 zunahm. Es wird ein Vergleich der Antibiotika-Resistenzraten der Anaerobier der verschiedenen Länder diskutiert.
Similar content being viewed by others
References
Tally, F. P., Cuchural, G. J., Jacobus, N. V., Gorbach, S. L., Aldrigde, K., Cleary, T., Finegold, S. M., Hill, G., Iannini, P., O'Keefe, J. P., Pierson, C. Nationwide study of the susceptibility of theBacteroides fragilis group in the United States. Antimicrob. Agents Chemother. 28 (1985) 675–677.
Cuchural, G. J., Tally, F. P., Jacobus, N. V., Aldrigde, K., Cleary, T., Finegold, S. M., Hill, G., Iannini, P., O'Keefe, J. P., Pierson, C., Crook, D., Russo, T., Hecht, D. Susceptibility of theBacteroides fragilis group in the United States. Analysis by site of infection, Antimicrob. Agents Chemother. 32 (1988) 717–722.
Soussy, C. J., Thibault, M., Duval, J. Activité antibactériennein vitro du céfotaxime sur les bactéries anaérobies. La Nouvelle Presse Médicale 10 (1981) 556–558.
Dublanchet, A., Durieux, R. Activité antibactérienne comparéein vitro de la céfalotine et de la céfoxitine sur les sous-espèces deBacteroides fragilis. Med. Mal. Inf. 9 (1979) 17–19.
Tytgat, F. Activité de sept antibiotiques surBacteroides fragilis. Ann. Microbiol. (Inst. Pasteur) 131 A (1980) 39–44.
Dubreuil, L., Devos, J., Neut, C., Romond, C. Etude de la sensibilité antibiotique des anaérobies stricts. Méd. Mal. Inf. 13 (1983) 478–483.
Dubreuil, L., Devos, J., Neut, C., Romond, C. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob. Agents Chemother. 25 (1984) 764–766.
Dubreuil, L., Devos, J., Romond, C. Etude de la sensibilitéin vitro des bacilles Gram négatifs anaérobies stricts vis-à-vis de la N. F. Thiénamycine et de diverses céphalosporines. Pathol. biol. 32 (1984) 429–432.
Dubreuil, L., Derriennic, M., Reynaud, A., Devos, J., Romond, C., Courtieu, A. L. Sensibilité des anaérobies stricts au métronidazole à la céfoxitine et à la clindamycine. Pathol. Biol. 33 (1985) 899–903.
Sedallian, A. Activité du céfotetan sur les bactéries anaérobies. Pathol. Biol. 34 (1986) 643–644.
Derriennic, M., Reynaud, A., Launay, C., Courtieu, A. L. Activitéin vitro de la pipéracilline, de l'amoxicilline, de la céfoxitine et du métronidazole face aux bactéries anaérobies strictes. La Nouvelle Presse Médicale 15 (1986) 2279–2281.
Derriennic, M., Reynaud, A., Launay, C., Courtieu, A. L. Activité comparée de neuf bêta lactamines de la clindamycine et du métronidazole sur les bactéries anaérobies strictes. Pathol. Biol. 35 (1987) 572–576.
Derriennic, M., Sedallian, A., Dubreuil, L.: Multicentric study on antibiotic susceptibility of anaerobic bacteria. (unpublished data, in press)
Garcia-Rodriguez, J. A., Garcia-Sanchez, J. E. Evolution ofBacteroides fragilis group antimicrobial susceptibility in Spain. Chemioterapia 4 (1985) (Suppl. 2) 806–809.
Tally, F. P., Cuchural, G. J., Jacobus, N. V., Gorbach, S. L., Aldridge, K. E., Cleary, T. J., Finegold, S. M., Hill, G. B., Iannini, P. B., Mc Closkey, R. V., O'Keefe, J. P., Pierson, C. L. Susceptibility of theBacteroides fragilis group in the United States in 1981. Antimicrob. Agents Chemother. 23 (1983) 536–540.
Avlami, A., Matsakas, E., Sahin, A., Giamarellou, H. The evolution of thein vitro activity of older and newer chemotherapeutics againstBacteroides fragilis group in Greece. Chemioterapia 4 (1985) (Suppl. 2) 808–809.
Borobio, M. V., Pascual, A., Perea, E. J. Increasing resistance ofBacteroides fragilis group strains to metronidazole in Spain between 1977 and 1982. Eur. J. Clin. Microbiol. 3 (1984) 153–155.
Gallusser, A., Bille, J. Antibiotic resistance patterns inBacteroides clinical isolates. Chemioterapia 4 (1985) (Suppl. 2) 815–816.
Heizmann, W., Heilmann, F., Werner, H. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin. Infection 15 (1987) 370–374.
Fox, A. R., Phillips, I. The antibiotic sensitivity ofBacteroides fragilis group in the United Kingdom. J. Antimicrob. Chemother 20 (1987) 477–488.
Bourgault, A. M., Harding, G. K., Smith, J. A., Horsman, G. B., Marrie, T. J., Lamothe, F. Survey of anaerobic susceptibility patterns in Canada. Antimicrob. Agents Chemother. 30 (1986) 798–801.
Cuchural, G. J., Malamy, M. H., Tally, F. P. β-lactamase mediated Imipenem resistance inBacteroides fragilis. Antimicrob. Agents Chemother. 30 (1986) 645–648.
Cuchural, G. J., Tally, F. P., Storey, J. R., Malamy, M. H. Transfer of β-lactamase associated cefoxitin resistance inBacteroides fragilis. Antimicrob. Agents Chemother. 29 (1986) 918–920.
Privitera, G., Ortisi, G., Rossi, R., Vigo, B., Setti, C. In vitro activity of a new penem FCE 22101 against anaerobic bacteria. Chemioterapia 4, 1985 (Suppl. 2) 271–273.
Reig, M., Campello, M. G., Baquero, F. Epidemiology of clindamycin resistance in theBacteroides fragilis group. J. Antimicrob. Chemother. 14 (1984) 595–603.
Dublanchet, A., Durieux, R. Isolement deBacteroides fragilis résistant à la clindamycine. La Nouvelle Presse Médicale 6 (1977) 464.
Dubreuil, L. In vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains. J. Antimicrob. Chemother. 20 (1987) (Suppl. B) 13–19.
Derriennic, M., Dubreuil, L., Reynaud, A. E., Courtieu, A. L. Comparativein vitro activities of four macrolides josamycin, erythromycin, spiramycin and roxithromycin against 424 anaerobic bacteria. Chemioterapia 6 (1987) (Suppl. 2) 159–160.
Olsson-Liljquist, B. In vitro activity of ciprofloxacin againstBacteroides, Haemophilus influenzae andBranhamella catarrhalis. Eur. J. Clin. Microbiol. 3 (1984) 370–371.
Dublanchet, A., Durieux, R. Sensibilité comparée de quelques bactéries aérobies et anaérobies à trois dérivés des 5 nitro-imidazoles, le métronidazole, l'ornidazole et la tinidazole. Ann. Microbiol. (Inst. Pasteur) 131 (1980) 45–59.
Sedallian, A. Sensibilité des anaérobies à huit antibiotiques. Pathol. Biol. 34 (1986) 645–647.
Dublanchet, A., Caillon, J., Edmond, J. P., Chardon, H., Drugeon, H. B. Isolation ofBacteroides strains with reduced sensitivity to 5 nitroimidazoles. Eur. J. Clin. Microbiol. 5 (1986) 346–347.
Reynaud, A., Drugeon, H. B., Derriennic, M., Courtieu, A. L. Sensibilité comparée de 207 souches de bactéries anaérobies strictes à la pipéracilline et à quatre autres antibiotiques. Pathol. Biol. 33 (1985) 891–895.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dubreuil, L., Romond, C., Derriennic, M. et al. Evolution in antibiotic susceptibility of bacteroides fragilis group strains in France based on periodic surveys. Infection 17, 197–200 (1989). https://doi.org/10.1007/BF01644030
Issue Date:
DOI: https://doi.org/10.1007/BF01644030